Regression of liver fibrosis by taurine in rats fed alcohol: Effects on collagen accumulation, selected cytokines and stellate cell activation

European Journal of Pharmacology

Volumn 647, Issue 1-3, 2010, Pages 161-170

  Devi, Shanmugam Lakshmi ^a   Viswanathan, Periyaswamy ^a   Anuradha, Carani V ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Ethanol; Experimental liver cirrhosis; Iron; Liver fibrosis; Oxidative stress; Taurine

Indexed keywords

ALCOHOL; ALPHA SMOOTH MUSCLE ACTIN; CARBONYL IRON; COLLAGEN; DESMIN; GLUTATHIONE; INTERLEUKIN 6; IRON; LIPID PEROXIDE; MYELOPEROXIDASE; TAURINE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL CONSUMPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL ACTIVATION; COLLAGEN METABOLISM; DRUG EFFICACY; ENZYME ACTIVITY; LIVER FIBROSIS; LIVER LEVEL; LIVER STRUCTURE; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; STELLATE CELL;

AMINO ACIDS; ANIMALS; ANTIOXIDANTS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; COLLAGEN; CYTOKINES; ETHANOL; HEPATIC STELLATE CELLS; INTERLEUKIN-6; IRON; LIVER; LIVER CIRRHOSIS; MALE; OXIDATIVE STRESS; PROTECTIVE AGENTS; RATS; RATS, WISTAR; TAURINE; TRACE ELEMENTS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77957296210     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.08.011     Document Type: Article

References (55)

1. Arezzini B., Lunghi B., Lungarella G., Gardi C. Iron overload enhances the development of experimental liver cirrhosis in mice. Int. J. Biochem. Cell Biol. 2003, 35:486-495.
2. Balkan J., Dogru-Abbasoglu S., Kanbaǧli O., Cevikbas U., Aykaç-Toker G., Uysal M. Taurine has a protective effect against thioacetamide-induced liver cirrhosis by decreasing oxidative stress. Hum. Exp. Toxicol. 2001, 20:251-254.
3. Baran H. Alterations of taurine in the brain of chronic kainic acid epilepsy model. Amino Acids 2006, 31:303-307.
4. Bradley P.P., Priebat D.A., Christensen R.D., Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 1982, 78:206-209.
5. Chen Y., Li S., Zhang X. Taurine inhibits deposition of extracellular matrix in experimental liver fibrosis in rats. Zhonghua Gan Zang Bing Za Zhi 1999, 7:165-174.
6. Dawson R., Baker D., Eppler B., Tang E., Shih D., Hern M., Hu H. Taurine inhibition of metal-stimulated catecholamine oxidation. Neurotox. Res. 2000, 2:1-15.
7. Devi S.L., Anuradha C.V. Mitochondrial damage, cytotoxicity and apoptosis in iron-potentiated alcoholic liver fibrosis: amelioration by taurine. Amino Acids 2010, 38:869-879.
8. Devi S.L., Viswanathan P., Anuradha C.V. Taurine enhances the metabolism and detoxification of ethanol and prevents hepatic fibrosis in rats treated with iron and alcohol. Environ. Toxicol. Pharmacol. 2008, 27:120-126.
9. Deviere J., Content J., Denys C., Vandenbussche P., Standing L., Wybran J., Dupont E. High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production. Clin. Exp. Immunol. 1989, 77:221-225.
10. Dey A., Cederbaum A.I. Alcohol and oxidative liver injury. Hepatology 2006, 43:S63-S74.
11. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82:70-77.
12. Erdamar H., Türközkan N., Ekremoǧlu M., Kurt Y., Yaman H. The effect of taurine on polymorphonuclear leukocyte functions in endotoxemia. Amino Acids 2007, 33:581-585.
13. Fang C., Lindros K.O., Badger T.M., Ronis M.J., Ingelman-Sundberg M. Zonated expression of cytokines in rat liver: effect of chronic ethanol and the cytochrome P450 2E1 inhibitor, chlormethiazole. Hepatology 1998, 27:1304-1310.
14. Gebhardt R. Oxidative stress, plant derived antioxidants and liver fibrosis. Planta Med. 2002, 68:289-296.
15. Gressner A.M., Weiskirchen R., Breitkopf K., Dooley S. Roles of TGF beta in hepatic fibrosis. Front. Biosci. 2002, 7:793-807.
16. Gurujeyalakshmi G., Wang Y., Giri S.N. Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-κB in mice. J. Pharmacol. Exp. Ther. 2000, 293:82-90.
17. Hoek J.B., Pastorino J.G. Cellular signaling mechanisms in alcohol-induced liver damage. Semin. Liver Dis. 2004, 24:257-272.
18. Hui A.Y., Friedman S.L. Molecular basis of hepatic fibrosis. Expert Rev. Mol. Med. 2003, 5:1-23.
19. Huxtable R.J. Physiological actions of taurine. Physiol. Rev. 1992, 72:101-163.
20. Iqbal M., Sharma S.D., Rezaza Deh H., Abdullia M., Hassan N., Athar M. Glutathione metabolizing enzymes and oxidative stress in Fe-NTA mediated liver injury. Redox Rep. 1996, 2:385-391.
21. Jiang Z.Y., Hunt J.V., Wolff S.P. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal. Biochem. 1992, 202:384-389.
22. Kakkar P., Das B., Viswanathan P.N. A modified spectrophotometric assay of superoxide dismutase. Indian J. Biochem. Biophys. 1984, 21:130-132.
23. López-Sánchez L.M., Corrales F.J., Barcos M., Espejo I., Muñoz-Castañeda J.R., Rodríguez-Ariza A. Inhibition of nitric oxide synthesis during induced cholestasis ameliorates hepatocellular injury by facilitating S-nitrosothiol homeostasis. Lab. Invest. 2010, 90:116-127.
24. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
25. McClain C.J., Song Z., Barve S.S., Hill D.B., Deaciuc I. Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 287:G497-G502.
26. Miller E.J., Rhodes R.K. Preparation and characterization of the different types of collagen. Methods Enzymol. 1982, 82:33-64.
27. Miyazaki T., Karube M., Matsuzaki Y., Ikegami T., Doy M., Tanaka N., Bouscarel B. Taurine inhibits oxidative damage and prevents fibrosis in carbon tetrachloride-induced hepatic fibrosis. J. Hepatol. 2005, 43:117-125.
28. Neuman M.G. Cytokines-central factors in alcoholic liver disease. Alcohol Res. Health 2003, 27:307-316.
29. Niehaus W.G., Samuelsson B. Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur. J. Biochem. 1968, 6:126-130.
30. Oudit G.Y., Sun H., Trivieri M.G., Koch S.E., Dawood F., Ackerley C., Yazdanpanah M., Wilson G.J., Schwartz A., Liu P.P., Backx P.H. L-type Ca2+ channels provide major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat. Med. 2003, 9:1187-1194.
31. Overall C.M., Wrana J.L., Sodek J. Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. J. Biol. Chem. 1989, 264:1860-1869.
32. Parola M., Pinzani M., Casini A., Albano E., Poli G., Gentilini A., Gentilini P., Dianzani M.U. Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha 1 (I) gene expression in human liver fat-storing cells. Biochem. Biophys. Res. Commun. 1993, 194:1044-1050.
33. Paz M.A., Lent R.W., Faris B., Franzblau C., Blumenfeld O.O., Gallop P.M. Aldehydes in native and denatured calf skin tropocollagen. Biochem. Biophys. Res. Commun. 1969, 34:221-229.
34. Pietrangelo A., Gualdi R., Casalgrandi G., Montosi G., Ventura E. Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents. J. Clin. Invest. 1995, 95:1824-1831.
35. Refik Mas M., Comert B., Oncu K., Vural S.A., Akay C., Tasci I., Ozkomur E., Serdar M., Mas N., Alcigir G., Yener N. The effect of taurine treatment on oxidative stress in experimental liver fibrosis. Heptagon. Res. 2004, 28:207-215.
36. Rotruck J.T., Pope A.L., Ganther H.E., Swanson A.B., Hafeman D.G., Hoekstra W.G. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973, 179:588-590.
37. Schmitt-Gräff A., Chakroun G., Gabbiani G. Modulation of perisinusoidal cell cytoskeletal features during experimental hepatic fibrosis. Virchows Arch. A Pathol. Anat. Histopathol. 1993, 422:99-107.
38. Schuller-Levis G.B., Park E. Taurine and its chloramine: modulators of immunity. Neurochem. Res. 2004, 29:117-126.
39. Sinha A.K. Colorimetric assay of catalase. Anal. Biochem. 1972, 47:389-394.
40. Stål P., Hultcrantz R. Iron increases ethanol toxicity in rat liver. J. Hepatol. 1993, 17:108-115.
41. Sudo K., Yamada Y., Moriwaki H., Saito K., Seishima M. Lack of tumor necrosis factor receptor type 1 inhibits liver fibrosis induced by carbon tetrachloride in mice. Cytokine 2005, 29:236-244.
42. Tabassum H., Rehman H., Banerjee B.D., Raisuddin S., Parvez S. Attenuation of tamoxifen-induced hepatotoxicity by taurine in mice. Clin. Chim. Acta 2006, 370:129-136.
43. Takatani T., Takahashi K., Uozumi Y., Shikata E., Yamamoto Y., Ito T., Matsuda T., Schaffer S.W., Fujio Y., Azuma J. Taurine inhibits apoptosis by preventing formation of the Apaf-1/caspase-9 apoptosome. Am. J. Physiol. Cell Physiol. 2004, 287:C949-C953.
44. Tasci I., Mas M.R., Vural S.A., Deveci S., Comert B., Alcigir G., Mas N., Akay C., Bozdayi M., Yurdaydin C., Bozkaya H., Uzunalimoglu O., Isik A.T., Said H.M. Pegylated interferon-alpha plus taurine in treatment of rat liver fibrosis. World J. Gastroenterol. 2007, 13:3237-3244.
45. Tasci I., Mas N., Mas M.R., Tuncer M., Comert B. Ultrastructural changes in hepatocytes after taurine treatment in CCl4 induced liver injury. World J. Gastroenterol. 2008, 14:4897-4902.
46. Toda K., Kumagai N., Tsuchimoto K., Inagaki H., Suzuki T., Oishi T., Atsukawa K., Saito H., Morizane T., Hibi T., Ishii H. Induction of hepatic stellate cell proliferation by LPS-stimulated peripheral blood mononuclear cells from patients with liver cirrhosis. J. Gastroenterol. 2000, 35:214-220.
47. Tsukamoto H., Rippe R., Niemelä O., Lin M. Roles of oxidative stress in activation of Kupffer and Ito cells in liver fibrogenesis. J. Gastroenterol. Hepatol. 1995, 10:S50-S53.
48. Tsukamoto H., Horne W., Kamimura S., Niemelä O., Parkkila S., Ylä-Herttuala S., Brittenham G.M. Experimental liver cirrhosis induced by alcohol and iron. J. Clin. Invest. 1995, 96:620-630.
49. Valerio L.G., Parks T., Petersen D.R. Alcohol mediates increases in hepatic and serum nonheme iron stores in a rat model for alcohol-induced liver injury. Alcohol. Clin. Exp. Res. 1996, 20:1352-1361.
50. Vollmar B., Richter S., Menger M.D. Liver ischemia/reperfusion induces an increase of microvascular leukocyte flux, but not heterogeneity of leukocyte trafficking. Liver 1997, 17:93-98.
51. Wang W.Y. Intestinal endotoxin translocation in endotoxemic rats. Sheng Li Ke Xue Jin Zhan 1995, 26:41-44.
52. Wang X., Cederbaum A.I. Acute ethanol pretreatment increases FAS-mediated liver injury in mice: role of oxidative stress and CYP2E1-dependent and -independent pathways. Free Radic. Biol. Med. 2007, 42:971-984.
53. Woessner J.F. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch. Biochem. Biophys. 1961, 93:440-447.
54. Wu Q.D., Wang J.H., Fennessy F., Redmond H.P., Bouchier-Hayes D. Taurine prevents high-glucose-induced human vascular endothelial cell apoptosis. Am. J. Physiol. 1999, 277:C1229-C1238.
55. Zhou J., Zhou J., Zhong X., Chen L., Yang X. Abnormal expressions of hepatocellular proteins and extracellular matrix in CCl4-induced liver injury in rats. Chin. Med. J. (Engl.) 1996, 109:366-371.